GambitBio develops affordable, at-home cancer screening solutions utilizing proprietary biomarkers in saliva samples. The company offers both rapid lateral flow tests and mail-in lab tests for convenient early detection. This platform empowers individuals with accessible health monitoring between clinical screenings, linking positive results to physician follow-up.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for cancer screening often require clinic visits, specialized equipment, and invasive procedures, creating barriers to early detection. This can lead to delayed diagnoses and reduced chances of successful treatment, particularly for individuals in remote areas or with limited access to healthcare facilities.
Solution
GambitBio is developing a saliva-based lateral flow test designed for at-home use, enabling individuals to proactively screen for common cancers. The test utilizes proprietary biomarkers to detect cancer signals in saliva samples, providing results within 30 minutes without the need for lab equipment or trained personnel. A companion smartphone app allows users to track past test results, set reminders for future tests, and connect with their healthcare provider for follow-up if necessary. By offering a convenient and accessible screening solution, GambitBio aims to improve early cancer detection rates and empower individuals to take control of their health.
Target Audience
The primary target audience includes individuals and families seeking a convenient and affordable way to proactively screen for common cancers, as well as healthcare providers looking for accessible early detection tools.
Features
- Saliva-based lateral flow assay for the detection of cancer biomarkers
- Proprietary biomarkers targeting unique post-translational modifications in proteins
- Rapid results in 30 minutes, eliminating the need for laboratory processing
- At-home testing format for convenient and private health monitoring
- Companion smartphone app for test tracking, reminders, and healthcare provider connection
- Direct-to-consumer distribution model via pharmacies and online channels